MEDI9447 Alone and in Combination with MEDI4736 in Adult Participants with Select Advanced Solid Tumors

Trial Identifier: D6070C00001
Sponsor: MedImmune, LLC
NCTID:: NCT02503774
Start Date: July 2015
Primary Completion Date: January 2021
Study Completion Date: March 2023
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
English (Australian) Translation
Spanish (United States) Translation
Korean Translation

Trial Locations

Country Location
AU Camperdown, AU, 2050
AU Parkville, AU, 3050
AU St Leonards, AU, 2065
AU Woolloongabba, AU, 4068
KR Seoul, KR, 03080
KR Seoul, KR, 06351
KR Seoul, KR, 05505
US, CA La Jolla, CA, US, 92093
US, CT New Haven, CT, US, 06510
US, FL Gainesville, FL, US, 32610
US, GA Atlanta, GA, US, 30318
US, MO Saint Louis, MO, US, 63156
US, NC Durham, NC, US, 27705
US, OH Cincinnati, OH, US, 45267
US, OH Columbus, OH, US, 43210
US, TN Nashville, TN, US, 37203
US, TX Dallas, TX, US, 75230
US, TX Houston, TX, US, 77030